HANNAH KIRCHER: Open Payments
NPI 1487302931 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 53 payments from 17 companies in 2025. Trend: 2023 $2,283 · 2024 $3,083 · 2025 $1,001
Food & beverage: $889Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $311 |
| Teva Pharmaceuticals USA, Inc. | 5 | $202 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| Lundbeck LLC | 2 | $31 |
Products named: VRAYLAR, REXULTI, UZEDY, CAPLYTA, FANAPT, TRINTELLIX, XYWAV, VYKAT XR.
Industry payments across TX — which companies pay providers there.
